This is the authors' abstract. We don't add key points for this paper.
The application of liquid chromatography/mass spectrometry (LC/MS) followed by principal components analysis (PCA) has been successfully applied to the screening of rat urine following the administration of three candidate pharmaceuticals. With this methodology it was possible to differentiate the control samples from the dosed samples and to identify the components of the mass spectrum responsible for the separation. These data clearly show that LC/MS is a viable alternative, or complementary, technique to proton NMR for metabonomics applications in drug discovery and development.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Plumb et al. (2002) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: